Evidence for the use of Levomepromazine for symptom control in the palliative care setting: a systematic review

BACKGROUND: Levomepromazine is an antipsychotic drug that is used clinically for a variety of distressing symptoms in palliative and end-of-life care. We undertook a systematic review based on the question “What is the published evidence for the use of levomepromazine in palliative symptom control?”...

Descripción completa

Detalles Bibliográficos
Autores principales: Dietz, Isabel, Schmitz, Andrea, Lampey, Ingrid, Schulz, Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3602665/
https://www.ncbi.nlm.nih.gov/pubmed/23331515
http://dx.doi.org/10.1186/1472-684X-12-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3602665/
https://www.ncbi.nlm.nih.gov/pubmed/23331515
http://dx.doi.org/10.1186/1472-684X-12-2

Ejemplares similares